AYTU vs TECH · rev $66.4M vs P/E 65, rev $1.22B
Aytu BioScience Inc (AYTU) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was up 1.8% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AYTU currently screens at market cap $24.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AYTU and TECH stock pages for the full models.
Not investment advice.